全文获取类型
收费全文 | 645篇 |
免费 | 35篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 14篇 |
基础医学 | 55篇 |
口腔科学 | 13篇 |
临床医学 | 47篇 |
内科学 | 258篇 |
皮肤病学 | 13篇 |
神经病学 | 19篇 |
特种医学 | 26篇 |
外科学 | 64篇 |
综合类 | 15篇 |
预防医学 | 23篇 |
眼科学 | 8篇 |
药学 | 27篇 |
中国医学 | 1篇 |
肿瘤学 | 97篇 |
出版年
2023年 | 2篇 |
2022年 | 11篇 |
2021年 | 17篇 |
2020年 | 9篇 |
2019年 | 4篇 |
2018年 | 21篇 |
2017年 | 14篇 |
2016年 | 13篇 |
2015年 | 13篇 |
2014年 | 17篇 |
2013年 | 28篇 |
2012年 | 33篇 |
2011年 | 33篇 |
2010年 | 17篇 |
2009年 | 32篇 |
2008年 | 31篇 |
2007年 | 45篇 |
2006年 | 50篇 |
2005年 | 30篇 |
2004年 | 24篇 |
2003年 | 22篇 |
2002年 | 10篇 |
2001年 | 14篇 |
2000年 | 14篇 |
1999年 | 10篇 |
1998年 | 17篇 |
1997年 | 10篇 |
1996年 | 18篇 |
1995年 | 10篇 |
1994年 | 9篇 |
1993年 | 5篇 |
1992年 | 17篇 |
1991年 | 8篇 |
1990年 | 13篇 |
1989年 | 7篇 |
1988年 | 5篇 |
1987年 | 9篇 |
1986年 | 10篇 |
1985年 | 6篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1960年 | 1篇 |
1954年 | 1篇 |
排序方式: 共有682条查询结果,搜索用时 31 毫秒
11.
目的对十年前后精神分裂症患者用药情况的变化进行调查分析.方法对十年前后两个五年段的各500份符合精神分裂症诊断标准的病历进行回顾性调查,并对各项指标进行对比分析.结果两组折算用药剂量经t检验差异无显著性(P>0.05);两组合并用药、合并抗胆碱药及疗效经χ2检验差异有显著性(P<0.01);十年后非典型抗精神病药物氯氮平在临床上的应用比例明显增大并上升为首位.结论十年前后两组抗精神病药的应用发生了明显变化,疗效好、副作用轻的非典型抗精神病药的应用比例明显增加. 相似文献
12.
13.
Saroj Neupane M.D. Naga VA Kommuri M.D. Noora Kazanji D.O. Pertha Chowdhury M.D. F.A.C.C. 《Echocardiography (Mount Kisco, N.Y.)》2016,33(11):1788-1789
Development of left ventricular pseudoaneurysm is a rare complication of mitral valve surgery and requires urgent surgical intervention. We describe a case of pseudoaneurysm of membranous septum following repeat mitral valve replacement with the use of multimodality imaging. 相似文献
14.
15.
Binod C. Raulo Chidananda Dash Shakti Rath Sukumar Chakrabarty Padmanav Rautray Jagannath Sahoo Rabindra N. Padhy 《急性病杂志》2012,1(2):156-158
This is an attempt of using in vitro cultured mesenchymal stem cells (MSCs) from bone marrow in joining of a fracture non-union. Bone marrow cells were obtained and differentially centrifuged for MSCs that were grown in vitro in mesenchymal stem cell basal medium aseptically, for 10 d. The cell mass was injected around the fracture non-union. Healthy conditions of development of tissue regeneration at the trauma site and due bone joining were recorded. It is concluded that in vitro cultured MSCs had a blithesome effect on the fracture non-union. 相似文献
16.
Thuluvath PJ Maheshwari A Jagannath S Arepally A 《Digestive diseases and sciences》2005,50(2):407-410
Primary prophylaxis with nonselective -blockers in high-risk subjects has been shown to be effective in reducing both esophageal variceal bleeding and mortality. Recently it has been suggested that band ligation may be a better option for primary prophylaxis. We compared nonselective -blockers with band ligation in patients with large varices (F2, F3) and elevated hepatic venous wedge pressure gradient (HVWPG, 12 mm Hg). All patients were prospectively followed for variceal bleeding, mortality, and treatment-related complications. Based on previous published studies, we estimated that 90 patients in each arm would be required to show a difference in bleeding rate. The study was prematurely terminated when we realized that our estimated sample size was inadequate to show a difference based on the observed bleeding rate. At the time of termination, 31 patients (Child A, 11; B, 14; C, 6), with a mean HVWPG of 19 ± 9.1 mm Hg, were randomized to either band ligation (group A; n = 16) or -blockers (group B; n = 15). Baseline demographics of both groups were similar and the mean follow-up period was 27.4 ± 12.9 months. During the follow-up, two patients in group A and one patient in group B had bleeding. Nine patients (29%; group A, six; group B, three; P = ns) died due to non-bleeding-related causes and five (16%) patients (group A, three; group B, two) underwent liver transplantation. Treatment-related complication were minimal in both groups. Despite the selection of high-risk patients, the observed bleeding rate was much lower than anticipated. Based on our observed bleeding rates, 424 patients would be required in each arm to show a difference between band ligation and -blocker therapy. 相似文献
17.
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma 总被引:7,自引:1,他引:7
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Lonial S Waller EK Richardson PG Jagannath S Orlowski RZ Giver CR Jaye DL Francis D Giusti S Torre C Barlogie B Berenson JR Singhal S Schenkein DP Esseltine DL Anderson J Xiao H Heffner LT Anderson KC;SUMMIT/CREST Investigators 《Blood》2005,106(12):3777-3784
Bortezomib, a proteasome inhibitor with efficacy in multiple myeloma, is associated with thrombocytopenia, the cause and kinetics of which are different from those of standard cytotoxic agents. We assessed the frequency, kinetics, and mechanism of thrombocytopenia following treatment with bortezomib 1.3 mg/m2 in 228 patients with relapsed and/or refractory myeloma in 2 phase 2 trials. The mean platelet count decreased by approximately 60% during treatment but recovered rapidly between treatments in a cyclic fashion. Among responders, the pretreatment platelet count increased significantly during subsequent cycles of therapy. The mean percent reduction in platelets was independent of baseline platelet count, M-protein concentration, and marrow plasmacytosis. Plasma thrombopoietin levels inversely correlated with platelet count. Murine studies demonstrated a reduction in peripheral platelet count following a single bortezomib dose without negative effects on megakaryocytic cellularity, ploidy, or morphology. These data suggest that bortezomib-induced thrombocytopenia is due to a reversible effect on megakaryocytic function rather than a direct cytotoxic effect on megakaryocytes or their progenitors. The exact mechanism underlying bortezomib-induced thrombocytopenia remains unknown but it is unlikely to be related to marrow injury or decreased thrombopoietin production. 相似文献
18.
Cardiac arrhythmias including supraventricular tachycardia are commonly encountered during pregnancy. The case of a young Indian woman with recurrent attacks of supraventricular tachycardia during pregnancy which was managed with adenosine and verapamil is reported. The possible mechanisms of maternal and fetal complications are discussed. 相似文献
19.
Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma 总被引:1,自引:0,他引:1
Rangaswamy Govindarajan Sundar Jagannath James T. Flick David H. Vesole Jeffrey Sawyer Bart Barlogie & Guido Tricot 《British journal of haematology》1996,95(2):349-353
Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) have been reported after autologous transplantation (AT) for lymphoma. It is not clear whether myeloablative therapy used in conjunction with autologous transplantation contributes to the development of MDS/AML or whether the conventional chemotherapy preceding the transplant, and administered over a prolonged period, causes these secondary malignancies. To address this issue, we examined 188 patients with multiple myeloma (MM) who had received AT. 71 patients with no more than one cycle of standard chemotherapy were enrolled in our Total Therapy program, designed to avoid exposure to alkylating agents prior to peripheral blood stem cell mobilization (group 1). The median duration of pre-transplant therapy in group 1 was 7.6 months and significantly shorter than the 24 months of 117 patients (group 2) with more prolonged conventional therapy ( P = 0.0001). All seven patients developing MDS post-transplantation belonged to group 2 ( P = 0.02); the median durations from initial therapy and first transplant were 66 months (range 38–86) and 24 months (range 9–39), respectively. Our findings provide evidence that prolonged standard-dose alkylating agent therapy prior to transplantation, rather than autotransplant-supported myeloablative treatment, is associated with development of MDS/AML. Stem cell damaging alkylator treatment should be avoided, not to compromise PBSC collection, but also to reduce the risk of treatment-related MDS/AML. 相似文献
20.
Jagannath S Puri K Kantsevoy S Thuluvath PJ 《Minerva gastroenterologica e dietologica》2008,54(2):125-130
Liver cancer is one of the most frequent solid cancers. The major risk factor associated with the development of hepatocellular carcinoma (HCC) is cirrhosis caused by hepatitis B, hepatitis C virus or chronic alcohol consumption. The overall prognosis of patients with HCC is very poor and this is mainly due to the advanced stages of cancer at presentation and also because of underlying cirrhosis. When HCC is diagnosed at early stages, prognosis is better with five-year disease free survival of around 50% with resection, or local ablative treatments such as radio-frequency ablation or percutaneous ethanol injection, and 70-80% with liver transplantation. Therefore, systematic screening of all the high-risk patients is the key to an early diagnosis of small HCC and the use of an appropriate treatment modality. The currently available tools for the screening, surveillance and diagnosis of HCC in the presence of cirrhosis remain sub-optimal. The advancements made in the past 10 years, however, have made HCC a potentially curable disease in a highly selected group of patients. This review will briefly discuss the current guidelines for surveillance and diagnosis of HCC in high-risk subjects and then review the potential role of endoscopic ultrasound and fine needle aspiration for the diagnosis of small HCC. 相似文献